Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain.

Neurons are the building blocks of the nervous system, which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.

neurodegenerative disease

Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias).

Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases.

The neurodegenerative diseases that RAVCARE focuses on are:

  • Alzheimer’s disease (AD) and other dementias
  • Parkinson’s disease (PD) and PD-related disorders
  • Prion disease
  • Motor neurone diseases (MND)
  • Huntington’s disease (HD)
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)

.

Diabetes management has traditionally relied on a combination of medication, blood sugar monitoring, and lifestyle adjustments. While these methods are crucial, they often involve significant burden and limitations. Enter digital therapeutics (DTx), a rapidly evolving field that leverages technology to offer personalized, data-driven interventions for chronic conditions like diabetes.

How Digital Therapeutics are Reshaping Diabetes Management

Diabetes management has traditionally relied on a combination of medication, blood sugar monitoring, and lifestyle adjustments. While these methods are crucial, they often involve significant burden and limitations. Enter digital therapeutics (DTx), a rapidly evolving field that leverages technology to offer personalized, data-driven interventions for chronic conditions like diabetes.

Read More »
en_USEnglish